Document is current
Any future updates will be listed below
-
Authors
Immanuel, Christian
Büttner, Thomas
Sprinkart, Alois M.
Nowak, Sebastian
Theis, Maike
Küppers, Jim
Fazeli, Sibgol
Fritzsche, Leander
Amin, Aland
Salih, Dilan
Ahmadzadehfar, Hojjat
Gärtner, Florian C.
Kreppel, Barbara
Conrad, Rupert
Ritter, Manuel
Essler, Markus
Krausewitz, Philipp
Marinova, Milka https://orcid.org/0000-0002-1856-5005
-
Funding
Funding for this research was provided by:
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 8 April 2026
Accepted: 8 July 2026
First Online: 22 July 2026
Declarations
Ethics approval: This is an observational study. The study was registered by the German Clinical Trial Register (DRKS00035087) and was approved by the institutional review board of the University Hospital Bonn (Ethics Committee vote 2024-19-BO), with a waiver of informed consent because of the retrospective study design.
Competing interests: Thomas Büttner received speaker honorary from Astellas. Philipp Krausewitz received speaker honorary from Novartis and Johnson and Johnson. The other authors have no competing interests to declare that are relevant to the content of this article.
